Product Main Parameters

Common Product Specifications

Product Manufacturing Process

The production of the TB IgG/IgM Combo Rapid Test involves a meticulous assembly of reagents and components optimized for high sensitivity and specificity. The antigens specific to TB IgG and IgM are immobilized on a nitrocellulose membrane. In the QL factory, these materials are assembled under controlled conditions to ensure consistent quality and performance. Each batch undergoes rigorous quality control testing to meet international standards for diagnostic sensitivity and specificity, ensuring reliability in various diagnostic settings.

Product Application Scenarios

The TB IgG/IgM Combo Rapid Test is crucial in areas with limited access to traditional TB diagnostics. It is particularly useful in field settings, community health clinics, and outbreak investigation sites due to its portable nature and simplicity of use. In factory settings, it serves as a valuable tool for initial TB screening among workers, especially in high-prevalence regions, supporting early detection and management strategies for TB control.

Product After-Sales Service

At QL Biotech, we provide comprehensive after-sales support, including training on test procedures, trouble-shooting guidance, and quality assurance. Customers can contact our dedicated service team for any queries related to the product's performance or usability.

Product Transportation

The TB IgG/IgM Combo Rapid Test kits are securely packaged to maintain integrity during transit. Transportation is conducted under temperature-regulated conditions to ensure the product's stability upon arrival at the factory or field use location.

Product Advantages

• Rapid results in under 30 minutes
• Easy to use with minimal training required
• Cost-effective for widespread screening
• Highly portable for field application

Product FAQ

• What is the TB IgG/IgM Combo Rapid Test?
  The TB IgG/IgM Combo Rapid Test is a factory-produced diagnostic tool designed to detect specific antibodies against Mycobacterium tuberculosis, facilitating rapid screening and detection of TB infections.
• How accurate is the TB IgG/IgM Combo Rapid Test?
  While highly useful for initial screening, the test's sensitivity and specificity may not match that of laboratory-based diagnostics. It is advised to use it alongside confirmatory tests in a factory setting.
• Where can the TB IgG/IgM Combo Rapid Test be used?
  The test is ideal for environments with limited access to laboratory infrastructure, such as remote clinics, community health programs, and factory health management setups.
• Is the test easy to use?
  Yes, the test is designed for simplicity, requiring minimal training. Each kit includes detailed instructions for use in factory and field scenarios.
• What specimens can be used with the test?
  The TB IgG/IgM Combo Rapid Test can be used with whole blood, serum, or plasma samples, making it versatile for different settings.
• What are the storage conditions for the test kits?
  Store the kits between 2-30°C to maintain test efficacy. Avoid freezing, as this may damage the components.
• How quickly can results be obtained?
  Results are typically available within 15 to 30 minutes, providing timely information for further assessment.
• Can the test be used for all age groups?
  Yes, the TB IgG/IgM Combo Rapid Test is suitable for use across different age groups, making it appropriate for broad screening initiatives in factories.
• What is the principle behind the test?
  The test detects TB-specific IgG and IgM antibodies through a colorimetric reaction on the test membrane, indicating exposure or infection status.
• Is there support available for troubleshooting?
  QL Biotech provides a dedicated support service for troubleshooting and guidance on the use of TB IgG/IgM Combo Rapid Test in factory conditions.

Product Hot Topics

• How does the TB IgG/IgM Combo Rapid Test benefit factory environments?
  In factory settings, early detection of TB cases is crucial to maintaining health standards and ensuring worker safety. The TB IgG/IgM Combo Rapid Test provides a rapid, reliable means of screening, allowing employers to take immediate action in potential outbreak situations. This leads to better health outcomes and minimizes the potential loss of productivity due to illness.
• Integrating TB IgG/IgM Combo Rapid Test into a broader diagnostic framework
  While the TB IgG/IgM Combo Rapid Test is valuable for initial screening, it should be part of a comprehensive diagnostic strategy. Factories and healthcare providers can integrate this test into larger workflows, supplementing it with confirmatory diagnostics for improved accuracy. This ensures that detected cases receive appropriate follow-up and treatment, maximizing the benefit of rapid testing.

Image Description